Entry Detail



General Information

Database ID:exR0087326
RNA Name:hsa-miR-140-3p
RNA Type:miRNA
Chromosome:chr16
Starnd:+
Coordinate:
Start Site(bp):69933142End Site(bp):69933162
External Links:hsa-miR-140-3p



Disease Information

Disease Name:Moyamoya Disease
Disease Category:Nervous System Diseases
MeSH ID:D009072
Type:Diseases Category/Nervous System Diseases
Alias:Progressive Intracranial Occlusive Arteropathy (Moyamoya)//Moyamoya Syndrome//Moya-Moya Disease//Disease, Moya-Moya//Moya Moya Disease//Cerebrovascular Moyamoya Disease//Moyamoya Disease, Primary//Disease, Primary Moyamoya//Moyamoya Diseases, Primary//Primary Moyamoya Disease//Primary Moyamoya Diseases//Moyamoya Disease, Classic//Classic Moyamoya Disease//Disease, Classic Moyamoya//Moyamoya Disease, Secondary//Secondary Moyamoya Disease



Expression Detail

GEO ID:GSE100488
Description:Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins
Experimental Design:Disease vs Control
Case Disease Type:Moyamoya Disease
Case Disease SubType:NA
Case Sample:Moyamoya Disease
Control Sample:Normal
Number of Case:11
Number of Control:10
Number of Samples:21





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ARF3
chr12
48935723
48957487
-
ARL1
chr12
101393116
101407772
-
ATP6V0D1
chr16
67438014
67481181
-
CBL
chr11
119206298
119313926
+
CDK6
chr7
92604921
92836594
-
CLASP1
chr2
121337776
121649587
-
CORO1C
chr12
108645109
108731596
-
CRCP
chr7
66114604
66154568
+
CRY2
chr11
45847118
45883248
+
NDST1
chr5
150485818
150558211
+
RNF220
chr1
44405194
44651724
+
SLC31A1
chr9
113221544
113264492
+
TMEM50A
chr1
25338317
25362361
+
ZDHHC6
chr10
112424428
112446917
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001880
chr9
110084263
110087285
+
hsa_circ_0000943
chr19
47421744
47440665
+
hsa_circ_0000032
chr1
25666964
25669564
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC245014.3
chr1
145281116
145281462
+
AL049840.4
chr14
103694516
103695050
-
AL356488.2
chr1
109100193
109100619
+
KCNQ1OT1
chr11
2608328
2699994
-
MIR17HG
chr13
91347820
91354579
+
MIR29B2CHG
chr1
207801518
207879115
-
MIR497HG
chr17
7015818
7019659
-
MIR663AHG
chr20
26167817
26251546
-
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE100488
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL20712
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:291
Sample treatment protocol:Whole blood samples were collected into disodium ethylenediaminotetraacetate tubes, centrifuged (4 °C, 3000 rpm, 30 minutes) immediately for plasma.
RNA Extract protocol:Total RNA was isolated from 200 uL of the pooled plasma using miRNeasy Serum/Plasma Kit (QIAGEN, Hilden, Germany).
RNA library preparation protocol:Cyanine 3-pCp-labeled microRNA was prepared from 2-uL of total RNA isolated from 200-uL of plasma, using Agilent's miRNA Complete Labeling and Hyb Kit (part number 5190-0456).



Reference

PMID:30157848
Title:Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line
Author:Uchino H, Ito M, Kazumata K, Hama Y, Hamauchi S, Terasaka S, Sasaki H, Houkin K
Journal:BMC Med Genomics. 2018 Aug 29;11(1):72.
Description:we employed a disease discordant monozygotic twin-based study design to unmask potential confounders.